Fig. 2. Changes of biomarkers during one-year eliglustat therapy: serum angiotensin converting enzyme (normal reference: 20-70 U/L) (A), serum total acid phosphatase (normal reference: 0.0-6.4 U/L) (B), and lyso-Gb1 in dried blood spot (normal reference: <10 ng/mL) (C).
© 2020 Korean Society of Medical Genetics and Genomics
